NCT02096406View on ClinicalTrials.gov

Outcomes of Angiotensin Converting Enzyme Inhibitor Management Strategies Prior to Coronary Artery Bypass

PHASE2CompletedINTERVENTIONAL
Enrollment

126

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

March 31, 2018

Study Completion Date

March 31, 2018

Conditions
Coronary Artery Disease
Interventions
DRUG

ACE/ARB continuation

ACE/ARB will be taken the morning of surgery with a sip of water

DRUG

ACE/ARB withdrawal

ACE/ARB will be stopped 48 hours prior to surgery

Trial Locations (1)

T6G 2B7

University of Alberta Hospital, Edmonton

All Listed Sponsors
lead

University of Alberta

OTHER

NCT02096406 - Outcomes of Angiotensin Converting Enzyme Inhibitor Management Strategies Prior to Coronary Artery Bypass | Biotech Hunter | Biotech Hunter